CAS: 19230-55-8; 3-Chloro-5-Methylpyridine

该化合物是属于含有氮的芳香热循环化合物的类丙烯的有机化合物,其分子式为C6H6ClN,表明存在氯原子和附于环的甲基组;该化合物具有三处的氯替代体和五处的丙烯环的甲基组,有助于其独特的化学特性;它一般是一种无色的黄色液体或固态,取决于温度和纯度. 3-氯-5-甲基丙烯因在制药,农用化学品和其他精密化学品的合成中应用而闻名.它表现出中度极性,在有机溶剂中溶解,但水溶性有限. 氯原子的存在可影响其再活动,使其得以参与各种化学反应,例如核分裂哲学替代.在处理这一化合物时,应当采取安全防范措施,因为如果进入或进入,可能会对健康造成风险.

结构式图片

相似化合物

329202-22-4 51269-82-0 847610-86-0

欧盟法规

ECHA物质C&L通报

合成工艺路线路线简述

    3-甲基吡啶-5-硼酸频哪醇酯置于copper Dichloride体系中,用 甲醇 用作溶剂,以204 Mg的收率获得3-氯-5-甲基吡啶
    参考文献:通过铱催化的芳烃硼化反应 1,3-二取代芳烃的间位卤化
    标题:通过铱催化的芳烃硼化反应 1,3-二取代芳烃的间位卤化
    摘要:我们报告了 1,3-二取代芳烃的间位卤化,通过使用铱催化的芳烃硼化化学形成 3,5-二取代芳基溴化物和氯化物.铱催化的芳烃与 B2Pin2 发生硼化反应,然后硼酸酯与溴化铜或氯化铜 (II) 反应,将芳基硼酸酯转化为相应的芳基卤化物.各种含有烷氧基,烷基,卤素,腈,酯,酰胺和新戊酰基的芳烃和 Tips 保护的醇以 46% 到 85% 的收率转化为相应的 3,5-二取代芳基溴化物和氯化物.此外,2,6-二取代和3-取代吡啶分别转化为4-卤代和5-卤代吡啶.
    Doi:10.1021/ja076498N

    海关参考信息

    专利信息


    专利号:US-8106031-B2
    优先权日:2006-05-02
    标题:Hydrolytically-resistant boron-containing therapeutics and methods of use
    发明人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A
    权利人:LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A; ANACOR PHARMACEUTICALS INC
    摘要:Compositions and methods of use of boron derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by fungi, yeast, bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.

    专利号:US-8853410-B2
    优先权日:2009-04-30
    标 题:Process for preparing substituted isoxazoline compounds and their precursors
    发明人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN
    权利人:RACK MICHAEL; KOERBER KARSTEN; KAISER FLORIAN; BASF SE
    摘要:The present invention relates to a new method of preparing halogenated styrene compounds of formula (VIII) n nwhich are precursors in the process of synthesis of substituted isoxazoline compounds of formula (I)n n nwherein R 1 to R 5 , R 8 and R 9 are described as in the description.n n The present invention relates further to the synthesis of compounds of formula (I) starting from acetophenones. The desired styrenes of formula are prepared from the appropriate substituted acetophenone. Asides bromo anilines react with formoxime. Obtained oximes undergo a cycloaddition with the styrenes and give isoxazolines. Compounds of formula (I) can then be prepared in a palladium catalyzed carbonylative amination reaction of the isoxazolines.

    专利号:US-10995078-B2
    优先权日:2013-03-13
    标 题:Compounds and compositions for inhibition of FASN
    发明人:BAIR KENNETH W; LANCIA JR DAVID R; LI HONGBIN; LOCH JAMES; LU WEI; MARTIN MATTHEW W; MILLAN DAVID S; SCHILLER SHAWN E R; TEBBE MARK J
    权利人:FORMA THERAPEUTICS INC
    摘要:The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

    专利号:WO-2023114200-A2
    优先权日:2021-12-14
    标题 :Methods for the synthesis of complement factor d inhibitors and intermediates thereof

    专利号:US-12336981-B2
    优先权日:2010-09-03
    标题 :Compounds and compositions for the inhibition of NAMPT
    发明人:BAIR KENNETH W; BAUMEISTER TIMM R; BUCKMELTER ALEXANDRE J; CLODFELTER KARL H; DRAGOVICH Peter; GOSSELIN FRANCIS; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; ROTH BRUCE; SMITH CHASE C; WANG ZHONGGUO; YUEN PO-WAI; ZHENG XIAOZHANG
    权利人:VALO HEALTH INC; GENENTECH INC
    摘要:The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

    专利号:US-9676721-B2
    优先权日:2010-09-03
    标题 :Compounds and compositions for the inhibition of NAMPT
    发明人:BAIR KENNETH W; BUCKMELTER ALEXANDRE J; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG
    权利人:BAIR KENNETH W; BUCKMELTER ALEXANDRE J; HAN BINGSONG; LIN JIAN; REYNOLDS DOMINIC J; SMITH CHASE C; WANG ZHONGGUO; ZHENG XIAOZHANG; FORMA TM LLC
    摘要:The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below.
    杭州氟药药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fluoropharm.cn
    电话:0571-85586753;13336034509👤
    📞 杭州氟药药业有限公司⚠️参考联系方式

    电话: 0571-85586753;13336034509
    邮件:sales@fluoropharm.com
    网址: http://www.fluoropharm.cn
    地址:浙江省杭州市滨江区西兴街道江陵路88号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    浙江省杭州市滨江区西兴街道江陵路88号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/bf01164704
    摘要:Shvekhgeimer M-A. Synthesis of halogenopyridines (review). Chemistry of Heterocyclic Compounds. 1996 Sep;32(9):987–1015. doi: 10.1007/bf01164704.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知